MA[pilcrow sign]lnlycke acquires patent to detect infected wounds.
NORDIC BUSINESS REPORT-June 6, 2019-MA[pilcrow sign]lnlycke acquires patent to detect infected wounds
(C)2019 M2 COMMUNICATIONS http://www.m2.com
Swedish medical solutions company Molnlycke said on Wednesday that it plans to acquire a patent that will help detect infections in wounds.
Under the terms of the agreement, Molnlycke has agreed to acquire the patent from Swedish regional innovation company, Innovation Skane.
Skane's technology can detect infections and alert caregivers that the wound needs attention. It will help to minimise the prophylactic use of antibiotics and reduce the risk of complications related to infections. Once developed, the patent will play a major role in reducing the unnecessary use of antibiotics in wound care.
According to the companies, the incidence of infection in hard-to-heal chronic wounds, such as diabetic foot ulcers and venous leg ulcers, is high and one in 20 patients undergoing surgery will develop a surgical site infection. However, infected wounds are costly, difficult to manage and hard to detect. In many cases, expensive antimicrobials are used prophylactically to prevent infections or to treat them once they have been established.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Publication:||Nordic Business Report|
|Date:||Jun 6, 2019|
|Previous Article:||Starbreeze reports on resolutions at 2019 AGM.|
|Next Article:||Elekta's Unity MR-Linac wins 2019 'Medical Device Engineering Breakthrough' award from MedTech Breakthrough.|